{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:06:04Z","timestamp":1792307164926,"version":"4.4.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejmech.2020.113046","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T11:26:13Z","timestamp":1606303573000},"page":"113046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Radiotracers for positron emission tomography (PET) targeting tumour-associated carbonic anhydrase isoforms"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-3374","authenticated-orcid":false,"given":"Valeria","family":"Burianova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Kalinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Krasavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.113046_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13244-019-0703-0","article-title":"How clinical imaging can assess cancer biology","volume":"10","author":"Garc\u00eda-Figueiras","year":"2019","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejmech.2020.113046_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003848","article-title":"In\u00a0vivo imaging in cancer","volume":"2","author":"Condeelis","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ejmech.2020.113046_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40658-020-00290-2","article-title":"State of the art in total body PET","volume":"7","author":"Vandenberghe","year":"2020","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ejmech.2020.113046_bib4","doi-asserted-by":"crossref","first-page":"165717","DOI":"10.1016\/j.bbadis.2020.165717","article-title":"Tumour functional imaging by PET","volume":"1866","author":"Abrantes","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2020.113046_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1053\/j.sult.2008.05.006","article-title":"Emission tomography \u2013 computed tomography: the historical perspective","volume":"29","author":"Townsend","year":"2008","journal-title":"Semin. Ultrasound CT MRI"},{"key":"10.1016\/j.ejmech.2020.113046_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00259-008-0951-6","article-title":"Combined PET\/MRI: a new dimension in whole-body oncology imaging?","volume":"36","author":"Antoch","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2020.113046_bib7","series-title":"Positron Emission Tomography: Basic Sciences","author":"Bailey","year":"2005"},{"key":"10.1016\/j.ejmech.2020.113046_bib8","first-page":"518","article-title":"About a case of elastofibroma dorsi: a rare benign tumor with moderate uptake of 18F-FDG","volume":"39","author":"Bouvet","year":"2015","journal-title":"Med. Nucl."},{"key":"10.1016\/j.ejmech.2020.113046_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1470-2045(11)70183-8","article-title":"Development and experimental medicine applications of PET in oncology: a historical perspective","volume":"13","author":"Jones","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2020.113046_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s10350-008-9236-1","article-title":"PET\/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer","volume":"51","author":"Nagata","year":"2008","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.ejmech.2020.113046_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.sult.2019.07.006","article-title":"Non-FDG radiopharmaceuticals in head and neck PET imaging: current techniques and future directions","volume":"40","author":"Eisenmenger","year":"2019","journal-title":"Semin. Ultrasound CT MRI"},{"key":"10.1016\/j.ejmech.2020.113046_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12272-019-01185-2","article-title":"Warburg effect and its role in tumourigenesis","volume":"42","author":"Lebelo","year":"2019","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2020.113046_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-020-00658-7","article-title":"Pathophysiological implications of hypoxia in human diseases","volume":"27","author":"Chen","year":"2020","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.ejmech.2020.113046_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2967\/jnumed.113.126615","article-title":"A\u00a0comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers","volume":"55","author":"Carlin","year":"2014","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.113046_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","author":"Supuran","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2020.113046_bib16","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2020.113046_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543776.2018.1523897","article-title":"Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2020.113046_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2020.113046_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo8020025","article-title":"Carbonic anhydrases and metabolism","volume":"8","author":"Supuran","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2020.113046_bib20","first-page":"773","article-title":"Differential regulation and prognostic significance of endogenous hypoxic markers in endometrial carcinomas","volume":"39","author":"Dong Soo","year":"2018","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ejmech.2020.113046_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/14756366.2017.1411350","article-title":"Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma","volume":"33","author":"Lucarini","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051312","article-title":"Insight into the development of PET radiopharmaceuticals for oncology","volume":"12","author":"Lau","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2020.113046_bib23","first-page":"57","article-title":"Review of 18 F-FDG synthesis and quality control, Biomed","volume":"2","author":"Yu","year":"2006","journal-title":"Imaging Interv. J."},{"key":"10.1016\/j.ejmech.2020.113046_bib24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2174\/156802610791384225","article-title":"Design and development of molecular imaging probes","volume":"10","author":"Chen","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib25","series-title":"Pharmacological Prerequisites for PET Ligands and Practical Issues in Preclinical PET Research BT - PET Chemistry","first-page":"317","author":"Ametamey","year":"2007"},{"key":"10.1016\/j.ejmech.2020.113046_bib26","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.7150\/thno.21848","article-title":"Past, present, and future: development of theranostic agents targeting carbonic anhydrase IX","volume":"7","author":"Lau","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2020.113046_bib27","series-title":"Carbonic Anhydrase Inhibitors for the Treatment of Tumors: Therapeutic, Immunologic, and Diagnostic Tools Targeting Isoforms IX and XII","author":"Ilies","year":"2019"},{"key":"10.1016\/j.ejmech.2020.113046_bib28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(09)60251-8","article-title":"Monoclonal antibodies for cancer immunotherapy","volume":"373","author":"Weiner","year":"2009","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejmech.2020.113046_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.ejmech.2020.113046_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.2910380406","article-title":"Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney","volume":"38","author":"Oosterwijk","year":"1986","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2020.113046_bib31","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.3390\/ijms140611402","article-title":"Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma","volume":"14","author":"Oosterwijk-Wakka","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2020.113046_bib32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.bjc.6601617","article-title":"A\u00a0phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients","volume":"90","author":"Bleumer","year":"2004","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2020.113046_bib33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamaoncol.2016.4419","article-title":"Adjuvant weekly girentuximab following nephrectomy for high-risk renal cell carcinoma","volume":"3","author":"Chamie","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejmech.2020.113046_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1470-2045(07)70044-X","article-title":"Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial","volume":"8","author":"Divgi","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2020.113046_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.2011.41.2445","article-title":"Positron emission tomography\/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial","volume":"31","author":"Divgi","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2020.113046_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40336-016-0186-7","article-title":"The role of iodine-124 positron emission tomography in molecular imaging","volume":"4","author":"Mahajan","year":"2016","journal-title":"Clin. Transl. Imaging"},{"key":"10.1016\/j.ejmech.2020.113046_bib37","first-page":"155","article-title":"PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats","volume":"19","author":"Brouwers","year":"2004","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.ejmech.2020.113046_bib38","first-page":"510","article-title":"ImmunoPET imaging of renal cell carcinoma with 124I- and 89Zr-Labeled Anti-CAIX monoclonal antibody cG250 in mice, Cancer Biother","volume":"28","author":"Stillebroer","year":"2013","journal-title":"Radiopharm"},{"key":"10.1016\/j.ejmech.2020.113046_bib39","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00259-013-2679-1","article-title":"Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in\u00a0vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcino","volume":"41","author":"Cheal","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2020.113046_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eururo.2018.04.026","article-title":"Positron emission tomography\/computed tomography with 89Zr-girentuximab can aid in diagnostic dilemmas of clear cell renal cell carcinoma suspicion","volume":"74","author":"Hekman","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejmech.2020.113046_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/203601","article-title":"Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients","volume":"2014","author":"van de Watering","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2020.113046_bib42","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00259-019-04358-9","article-title":"Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET\/CT in patients with newly diagnosed metastatic renal cell carcinoma","volume":"46","author":"Verhoeff","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2020.113046_bib43","unstructured":"Telix International Pty Ltd, 89Zr-TLX250 for PET\/CT Imaging of ccRCC- ZIRCON Study (89ZR-TLX250), (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03849118 (accessed November 19, 2020)."},{"key":"10.1016\/j.ejmech.2020.113046_bib44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.11142","article-title":"Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma","volume":"105","author":"Chrastina","year":"2003","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2020.113046_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.apradiso.2018.10.021","article-title":"Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61 Cu and 64 Cu and its biological testing","volume":"143","author":"\u010cepa","year":"2019","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2020.113046_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apradiso.2017.12.013","article-title":"In\u00a0vitro evaluation of the monoclonal antibody 64Cu-IgG M75 against human carbonic anhydrase IX and its in\u00a0vivo imaging","volume":"133","author":"\u010cepa","year":"2018","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2020.113046_bib47","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1002\/ejic.200900358","article-title":"Metal complexes of 4,11-Dimethyl-1,4,8,11-tetraazacyclotetradecane-1,8-bis(methylphosphonic acid) - thermodynamic and formation\/decomplexation kinetic studies","author":"Svobodov\u00e1","year":"2009","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib48","doi-asserted-by":"crossref","first-page":"14928","DOI":"10.1039\/D0RA02934C","article-title":"Cysteine specific bioconjugation with benzyl isothiocyanates","volume":"10","author":"Petri","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.113046_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2005.06.031","article-title":"Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines","volume":"76","author":"Troost","year":"2005","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2020.113046_bib50","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2967\/jnumed.109.073189","article-title":"PET of hypoxia with89Zr-labeled cG250-F(ab\u2019)2 in head and neck tumors","volume":"51","author":"Hoeben","year":"2010","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.113046_bib51","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/cmdc.201800130","article-title":"Fully automated production and characterization of 64Cu and proof-of-principle small-animal PET imaging using 64Cu-labelled CA XII targeting 6A10 Fab","volume":"13","author":"Fiedler","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.113046_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.addr.2016.06.007","article-title":"Peptide-based imaging agents for cancer detection","volume":"110\u2013111","author":"Sun","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2020.113046_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0038279","article-title":"Optimization of a novel peptide ligand targeting human carbonic anhydrase IX","volume":"7","author":"Rana","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2020.113046_bib54","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bmc.2019.01.014","article-title":"Fluorine-18 click radiosynthesis and microPET\/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX","volume":"27","author":"Jia","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib55","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1021\/ja00504a004","article-title":"Lipophilic [2.2.2] cryptands as phase-transfer catalysts. Activation and nucleophilicity of anions in aqueous-organic two-phase systems and in organic solvents of low polarity","volume":"101","author":"Landini","year":"1979","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.113046_bib56","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.2147\/IJN.S176287","article-title":"CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors","volume":"13","author":"Zhu","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2020.113046_bib57","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0883-2889(88)90056-1","article-title":"The radiosynthesis of a 11C-labelled carbonic anhydrase inhibitor-[carbonyl-11C]acetazolamide","volume":"39","author":"Le Bars","year":"1988","journal-title":"Int. J. Radiat. Appl. Instrumentation. Part."},{"key":"10.1016\/j.ejmech.2020.113046_bib58","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1016\/j.bmcl.2011.09.102","article-title":"Radiosynthesis of three [11C]ureido-substituted benzenesulfonamides as PET probes for carbonic anhydrase IX in tumors","volume":"21","author":"Asakawa","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.113046_bib59","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/(SICI)1099-1344(200004)43:5<425::AID-JLCR327>3.0.CO;2-U","article-title":"Synthesis of 16\u03b1-[18F]fluoroestradiol-3,17\u03b2-disulphamate","volume":"43","author":"R\u00f6mer","year":"2000","journal-title":"J.\u00a0Label. Compd. Radiopharm."},{"key":"10.1016\/j.ejmech.2020.113046_bib61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0969-8043(02)00184-7","article-title":"Distribution of fluoro-estradiol-3,17b-disulfamate in rats, tumour-bearing mice and piglets","volume":"57","author":"Brust","year":"2002","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2020.113046_bib62","series-title":"Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry","author":"Kolb","year":"2010"},{"key":"10.1016\/j.ejmech.2020.113046_bib63","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11307-014-0730-7","article-title":"Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [18 F]VM4-037 determined from PET\/CT scans in healthy volunteers","volume":"16","author":"Doss","year":"2014","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.ejmech.2020.113046_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00261-015-0599-1","article-title":"PET\/CT imaging of renal cell carcinoma with 18F-VM4-037: a phase II pilot study","volume":"41","author":"Turkbey","year":"2016","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.ejmech.2020.113046_bib65","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11307-015-0831-y","article-title":"[18F]VM4-037 MicroPET imaging and biodistribution of two in\u00a0vivo CAIX-expressing tumor models","volume":"17","author":"Peeters","year":"2015","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.ejmech.2020.113046_bib66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/14756366.2013.773994","article-title":"Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography","volume":"29","author":"Pan","year":"2014","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib67","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1152\/physrev.2000.80.2.681","article-title":"Carbon dioxide transport and carbonic anhydrase in blood and muscle","volume":"80","author":"Geers","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2020.113046_bib68","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib69","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/j.bmc.2017.04.007","article-title":"N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII","volume":"25","author":"Ivanova","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib70","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1039\/c3cc40858b","article-title":"New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides","volume":"49","author":"M\u00e9tayer","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2020.113046_bib71","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1016\/j.bmcl.2014.05.021","article-title":"Synthesis and evaluation of 18F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography","volume":"24","author":"Lau","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.113046_bib72","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2967\/jnumed.114.153288","article-title":"Trimeric radiofluorinated sulfonamide derivatives to achieve in\u00a0vivo selectivity for carbonic anhydrase IX-targeted PET imaging","volume":"56","author":"Lau","year":"2015","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.113046_bib73","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/14756366.2017.1308928","article-title":"Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging","volume":"32","author":"Zhang","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib74","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bmcl.2018.01.060","article-title":"Acetazolamide-based [18F]-PET tracer: in\u00a0vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors","volume":"28","author":"More","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.113046_bib75","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nchem.2158","article-title":"Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation","volume":"7","author":"Wichert","year":"2015","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2020.113046_bib76","doi-asserted-by":"crossref","first-page":"56471","DOI":"10.18632\/oncotarget.10602","article-title":"[64Cu]XYIMSR-06: a dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma","volume":"7","author":"Minn","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2020.113046_bib77","series-title":"Nuclear Imaging and Radiotherapeutics Agents Targeting Carbonic Anhydrase Ix and Uses Thereof","author":"Yang","year":"2016"},{"key":"10.1016\/j.ejmech.2020.113046_bib78","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1021\/acs.molpharmaceut.8b01210","article-title":"Targeting CAIX with [ 64 Cu]XYIMSR-06 small molecular radiotracer enables noninvasive PET imaging of malignant glioma in U87 MG tumor cell xenograft mice","volume":"16","author":"Yang","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2020.113046_bib79","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1039\/C4DT03206C","article-title":"Synthesis of sulfonamide conjugates of Cu(ii), Ga(iii), In(iii), Re(v) and Zn(ii) complexes: carbonic anhydrase inhibition studies and cellular imaging investigations","volume":"44","author":"Dilworth","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2020.113046_bib80","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/acs.molpharmaceut.5b00934","article-title":"PET imaging of carbonic anhydrase IX expression of HT-29 tumor xenograft mice with 68Ga-labeled benzenesulfonamides","volume":"13","author":"Lau","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2020.113046_bib81","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1021\/acs.jmedchem.6b00623","article-title":"Synthesis and in\u00a0vivo biological evaluation of 68Ga-labeled carbonic anhydrase IX targeting small molecules for positron emission tomography","volume":"59","author":"Sneddon","year":"2016","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420310187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420310187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:30:08Z","timestamp":1759329008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420310187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":81,"alternative-id":["S0223523420310187"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.113046","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotracers for positron emission tomography (PET) targeting tumour-associated carbonic anhydrase isoforms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.113046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113046"}}